Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on CAPR
    No News Available
    Capricor Therapeutics Announces Proposed Public Offering of Common St...
    4:00p ET December 4 '25 GlobeNewswire
    Capricor Therapeutics Announces Positive Topline Results from Pivotal...
    7:19a ET December 3 '25 GlobeNewswire
    Capricor Therapeutics Presents New Data Demonstrating a Scalable Fram...
    9:00a ET November 24 '25 GlobeNewswire
    Capricor Therapeutics Reports Third Quarter 2025 Financial Results an...
    4:01p ET November 10 '25 GlobeNewswire
    Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Cont...
    10:16a ET November 10 '25 GlobeNewswire
    Capricor Therapeutics, Inc. (CAPR) Investigation: Bronstein, Gewirtz ...
    11:21a ET November 9 '25 ACCESSWIRE
    Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johns...
    4:05p ET November 4 '25 GlobeNewswire
    Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, ...
    11:10a ET November 4 '25 ACCESSWIRE
    Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines D...
    9:15a ET November 3 '25 GlobeNewswire
    Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against...
    11:14a ET November 2 '25 ACCESSWIRE

    Market data provided by News provided by